Company: VERA
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0000950170-25-064733
Chunk: 1

Company: Vera Therapeutics, Inc.
Filing Date: 2025-05-07
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
31, 2024, respectively

     64

     64

     Additional paid-in capital

     1,047,225

     1,037,948

     Accumulated other comprehensive income

     654

     393

     Accumulated deficit

     (512,944
     )

     (461,250
     )

     Total stockholders’ equity

     534,999

     577,155

     Total liabilities and stockholders’ equity
      
     $
     610,167

     $
     655,681

The accompanying notes are an integral part of these unaudited condensed financial statements.